BRCA1 and pancreatic cancer: pedigree findings and their causal relationships.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Cancer Genetics and Cytogenetics

• Publication date

  2005-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CANCERGENCYTO.2004.01.032PMID 15796958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2004

  2004cited by this paper
• Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma

  2004cited by this paper
• Clinicopathologic and Molecular Features of Pancreatic Adenocarcinoma Associated with Peutz-Jeghers Syndrome

  2003cited by this paper
• DNA mismatch repair defects: role in colorectal carcinogenesis.

  2002cited by this paper
• Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program.

  2002cited by this paper
• A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34.

  2002cited by this paper
• Cancer Incidence in BRCA1 mutation carriers.

  2002cited by this paper
• Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas

  2002cited by this paper
• A BRCA2 germ‐line mutation in familial pancreatic carcinoma

  2001cited by this paper
• STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas.

  2001cited by this paper
• The Role of Genetic Factors in the Etiology of Pancreatic Adenocarcinoma: An Update

  2001cited by this paper
• Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

  2001cited by this paper
• Hereditary Pancreatic Cancer

  2001cited by this paper
• Very high risk of cancer in familial Peutz-Jeghers syndrome.

  2000cited by this paper
• Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.

  2000cited by this paper
• Risk factors for cancer in hereditary pancreatitis. International Hereditary Pancreatitis Study Group.

  2000cited by this paper
• Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers.

  1999cited by this paper
• Cancer risks in BRCA2 mutation carriers.

  1999cited by this paper
• Global cancer statistics

  1999cited by this paper
• Pancreatic cancer.

  1999cited by this paper
• Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

  1998cited by this paper
• Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.

  1998cited by this paper
• A serine/threonine kinase gene defective in Peutz–Jeghers syndrome

  1998cited by this paper
• Peutz-Jeghers syndrome is caused by mutations in a novel serine threoninekinase

  1998cited by this paper
• The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.

  1997cited by this paper
• Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis

  1997cited by this paper
• Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

  1997cited by this paper
• de la Chapelle, A.

  1997cited by this paper
• Pancreatic carcinoma.

  1997cited by this paper
• Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.

  1996cited by this paper
• Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

  1996cited by this paper
• Familial pancreatic cancer: a review.

  1996cited by this paper
• Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene

  1996cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

  1995cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Mutations of the adenomatous polyposis coli gene in the mutation cluster region: Comparison of human pancreatic and colorectal cancers

  1994cited by this paper
• Neoplastic diseases in families of breast cancer patients.

  1994cited by this paper
• Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.

  1993cited by this paper
• Frequent somatic mutations of the APC gene in human pancreatic cancer.

  1992cited by this paper
• Identification and characterization of the familial adenomatous polyposis coli gene

  1991cited by this paper
• Identification of FAP locus genes from chromosome 5q21.

  1991cited by this paper
• Pancreatic Cancer and the Familial Atypical Multiple Mole Melanoma (FAMMM) Syndrome

  1991cited by this paper
• Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study.

  1985cited by this paper
• Malignant neoplasms in the families of patients with ataxia-telangiectasia.

  1976cited by this paper

• Germline genetic profiling utilizing multigene panel testing in Jordanian patients with pancreatic cancer: a comprehensive cancer center experience.

  2026cites this paper
• Current oncological management options for hepato-pancreato-biliary cancers

  2025cites this paper
• BRCA mutations detected by tumour next-generation sequencing in non-small cell lung cancer: impact on response to therapy and disease course

  2023cites this paper
• Stratifying Risk for Pancreatic Cancer by Multiplexed Blood Test

  2023cites this paper
• Leptomeningeal carcinomatosis in a patient with PALB2-mutated pancreatic adenocarcinoma: A case report and review of the literature

  2023cites this paper
• Genetic features of pathogenesis in pancreatic adenocarcinomas

  2023cites this paper
• Advances in the management of pancreatic cancer

  2023cites this paper
• Clinical risk management of breast, ovarian, pancreatic, and prostatic cancers for BRCA1/2 variant carriers in Japan

  2023cites this paper
• Precision Medicine for BRCA/PALB2-Mutated Pancreatic Cancer and Emerging Strategies to Improve Therapeutic Responses to PARP Inhibition

  2022cites this paper
• The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.

  2022cites this paper
• Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival

  2022cites this paper
• Concurrent Germline BRCA1/2 and Mismatch Repair Mutations in Young-Onset Pancreatic and Colorectal Cancer: The Importance of Comprehensive Germline and Somatic Characterization to Inform Therapeutic Options.

  2022cites this paper
• Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review

  2022cites this paper
• Present status and perspective of perioperative chemotherapy for patients with resectable pancreatic cancer in Japan.

  2022cites this paper
• Genetic landscape of pancreatic cancer: a narrative review.

  2022cites this paper
• Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma.

  2022cites this paper
• Identification of New Regulators of Pancreatic Cancer Cell Sensitivity to Oxaliplatin and Cisplatin

  2022cites this paper
• Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King

  2021cites this paper
• Pancreatic cancer.

  2021cites this paper
• Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies

  2021cites this paper
• Pancreatic ductal adenocarcinoma in the era of precision medicine.

  2021cites this paper
• Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer

  2020cites this paper
• CMAR_A_211151 2731..2742

  2020cites this paper
• The Emerging Role of Microbiota and Microbiome in Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• BRCA Mutations in Pancreas Cancer: Spectrum, Current Management, Challenges and Future Prospects

  2020cites this paper
• New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation.

  2020cites this paper
• Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains

  2019cites this paper
• Pancreatic Cancer

  2019cites this paper
• Familial Pancreatic Cancer and Surveillance of High-Risk Individuals

  2019cites this paper
• Surveillance of Individuals with a Family History of Pancreatic Cancer and Inherited Cancer Syndromes: A Strategy for Detecting Early Pancreatic Cancers

  2019cites this paper
• Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer

  2019cites this paper
• Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild‐type BRCA pancreatic ductal adenocarcinoma

  2018cites this paper
• Title Familial pancreatic cancer: Concept, management and issues

  2018cites this paper
• GENETIC EVOLUTION AND PROGNOSTIC DETERMINANTS OF PANCREATIC CANCER ON LONGITUDINAL LIQUID BIOPSIES

  2018cites this paper
• Role of gata4 in pancreatic physiology and carcinogenesis

  2017influential citation
• The role of PALB2 in BRCA1/2-mediated DNA repair and tumor suppression

  2017influential citation
• Familial pancreatic cancer: Concept, management and issues

  2017cites this paper
• Pathopoiesis Mechanism of Smoking and Shared Genes in Pancreatic Cancer

  2017cites this paper
• Molecular and Genetic Basis of Pancreatic Carcinogenesis: Which Concepts May be Clinically Relevant?

  2016cites this paper
• Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

  2016cites this paper
• Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.

  2015cites this paper
• Endoscopic ultrasound and pancreatic cancer: Advancing the application of technology for early detection

  2015cites this paper
• Hereditary breast cancer syndromes and genetic testing

  2015cites this paper
• Genetic predisposition to pancreatic cancer.

  2014cites this paper
• Screening for pancreatic cancer.

  2014cites this paper
• TOPIC HIGHLIGHT

  2014cites this paper
• BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study

  2014cites this paper
• Topoisomerase IIα in Chromosome Instability and Personalized Cancer Therapy

  2014cites this paper
• BRCA1 and Oxidative Stress

  2014cites this paper
• NO MUTATIONS OR VARIANTS WERE DETECTED IN THE FOLLOWING

  2014cites this paper
• Select Population-Based and Translational Research for Improving Pancreatic Cancer Early Detection

  2014cites this paper
• Pancreatic cancer genomics: insights and opportunities for clinical translation

  2013cites this paper
• Hereditary breast/ovarian cancer syndrome: a primer for obstetricians/gynecologists.

  2013cites this paper
• Screening for Pancreatic Cancer: Why, How, and Who?

  2013cites this paper
• Molecular biology of adenocarcinoma of the pancreatic duct, current state and future therapeutic avenues.

  2013cites this paper
• Familial Breast Cancer: Genetic Testing

  2013cites this paper
• A Primer for Obstetricians/Gynecologists

  2013cites this paper
• Epidemiology of pancreatic cancer and the role of family history

  2013cites this paper
• Protein-protein interaction and SNP analysis in intraductal papillary mucinous neoplasm.

  2013cites this paper
• Significance of caveolin-1 regulators in pancreatic cancer.

  2013cites this paper
• Cancer of the Colon and Gastrointestinal Tract

  2013cites this paper
• Genetic testing by cancer site: pancreas.

  2012cites this paper
• CDKN2A is the main susceptibility gene in Italian pancreatic cancer families

  2012influential citation
• Asymptomatic pancreatic lesions: new insights and clinical implications.

  2012cites this paper
• Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer

  2012cites this paper
• Individuals at high-risk for pancreatic cancer development: management options and the role of surgery.

  2012cites this paper
• Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

  2012cites this paper
• Identifying Susceptibility Genes for Familial Pancreatic Cancer Using Novel High-Resolution Genome Interrogation Platforms

  2012cites this paper
• Trabajo Fin de Máster

  2012cites this paper
• Risk Factors of Familial Pancreatic Cancer in Japan: Current Smoking and Recent Onset of Diabetes

  2011cites this paper
• A novel in vitro pancreatic carcinogenesis model.

  2011cites this paper
• Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals

  2011influential citation
• Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy

  2011cites this paper
• Review of screening for pancreatic cancer in high risk individuals.

  2011cites this paper
• BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer

  2011cites this paper
• Genomics and pharmacogenomics of pancreatic adenocarcinoma

  2011cites this paper
• Title Clinical and pathological characteristics of Chinese patients withBRCA related breast cancer

  2010cites this paper
• Familial Pancreatic Cancer

  2010cites this paper
• Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

  2010cites this paper
• MED29 Possesses a Complex Role in Pancreatic Cancer

  2010cites this paper
• Upper gastrointestinal cancer predisposition syndromes.

  2010cites this paper
• Genetic/familial high-risk assessment: breast and ovarian.

  2010cites this paper
• Hereditary pancreatic cancer: a clinical perspective.

  2009cites this paper
• Pancreatic adenocarcinoma: new strategies for success.

  2009cites this paper
• Should Patients With a Strong Family History of Pancreatic Cancer Be Screened on a Periodic Basis for Cancer of the Pancreas?

  2009cites this paper
• Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer

  2009cites this paper
• Absence of germline BRCA1 mutations in familial pancreatic cancer patients

  2009cites this paper
• K-ras, BRCA1/2, and CHEK2 mutations and loss of heterozygosity at 9p, 17p, and 18q in sporadic adenocarcinoma of the pancreas

  2009cites this paper
• [Analysis of K-ras, BRCA1/2, CHEK2 mutations and microsatellite markers (loss of heterozygosity at 9p, 17p and 18q) in sporadic pancreas adenocarcinomas].

  2009cites this paper
• Concise handbook of familial cancer susceptibility syndromes - second edition.

  2008cites this paper
• Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations

  2008cites this paper
• Molecular Cancer Gene Expression Profiles in Primary Pancreatic Tumors and Metastatic Lesions of Ela-c-myc Transgenic Mice

  2008cites this paper
• Germline BRCA1 mutations predispose to pancreatic adenocarcinoma

  2008cites this paper
• Germline mutations in the tumour suppressor genes breast cancer antigen gene ( BRCA ) 1 and BRCA 2

  2007cites this paper
• Conditional inactivation of the BRCA1 tumour suppressor gene in the mouse ovarian surface epithelium in vitro and in vivo

  2007cites this paper
• Pancreatic cancer — Pathology

  2007cites this paper
• Association of genetic variants with pancreatic cancer.

  2007cites this paper
• Advances in counselling and surveillance of patients at risk for pancreatic cancer

  2007cites this paper
• Familial pancreatic cancer: from genes to improved patient care

  2007cites this paper